A. Trisomy of 21 chromosome

B. Mosaicism of 21 chromosome

C. Robersonian translocation of 21.21, 21.18

A. Liver

B. Lung

C. Kidney

A. Thrombasthenia

C. haemophilia

D. Thrombocytopenic purpura

A. Is a characteristic feature of malignancy

B. Lack of structural differentiation

C. Lack of functional differentiation

B. Go M G2 S G1

C. Go G1 S M G2

D. Go G1 G2 S M

A. Heart

B. Arteries

D. Capilaries

A. Eosinophils

C. Neutrophils

D. Normoblats

A. A specific type of chronic inflammation

B. Accumulation of modified macrophages

C. Initiated by a number of infectious and non infectious agents

B. Heart

C. Intestines

D. Kidneys

A. Metaplastic

C. Hyperplastic

D. Dysplastic

A. Lymph nodes

B. Liver

C. Spleen

B. Secondary union

C. Both of the above

D. None of the above

B. Growth factors

C. Hormones

D. Blood supply

A. Formation of sinusoids

B. Increases blood perfusion

C. Vitamin-A storage

A. Borderline lepromatous leprosy

C. Tuberculoid leprosy

D. Intermediate leprosy

A. None of the above

B. Osteoma

C. Chondrosarcoma

A. 60 mg

C. 600 mg

D. 0.06 mg

A. Kidney

B. Liver

C. Lung

A. High capacity to divide

B. Limited capacity to divide

C. Long life span as compared to lymphocytes

A. GABA receptors

B. Serotonergic receptors

D. Dopaminergic receptors

A. Bacteriophage

B. Redox text

D. Gene splicing

B. Thrombo embolism

C. Air embolism

D. Amniotic fluid embolism

A. 46 X Y, -14 t(14;21)

B. 47 X Y, -14 t(14;21)

C. 47 X &, (+2)

A. Congenital

B. Primary

D. Tetriary

A. Lymphocytes

B. Macrophages

D. Plasma cells

B. 46 XY

C. 46 XXY

D. 45 X

A. Trisomy 18

B. Turner syndrome

C. Trisomy 21

B. Inflammation

C. Blushing

D. Muscles during exercise

A. Lupus anticoagulant

B. Hemophilia

D. Liver disease

A. 0.5

B. 5

C. 2

A. Eosinophils

B. Plasma cells

D. Monocytes

A. Simple fracture

C. Comminuted fracture

D. Compound fracture

B. None of the above

C. Pulmonary embolism

D. Congestive heart failure

A. Bupivacaine

C. Lidocaine

D. Procaine

A. Leukotrienes cause bronchoconstriction

B. Arachidonic acid is metabolized to form prostaglandins and leukotrienes

D. COX is induced by cytokines at the site of inflammation

A. Pregnancy

B. Nephrotic syndorme

C. Newborn

D. Liver disease

A. Hamartoma

B. Choristoma

C. Plemorphic tumours

A. Metaplasia

B. Atrophy

C. Hypertrophy

A. Exacerbate the inflammatory response

C. Indicated in oral thrush

D. Can be safely given to immunocompromised patients

A. Papilloma

B. Lymphosarcoma

C. Hematoma

A. Ideterminate leprosy

C. Tuberculoid leprosy

D. Borderline tuberculoid leprosy

A. Decreased interstitial fluid

C. Decreased blood flow

D. Decreased capilary permeability

B. petechiae small pin point hemorrhages

C. Ecchymosis large extravasation of blood in to the skin and mucous membrane

D. Purpura small areas (1cm) of hemorrhage in to the skin and mucous membrane

B. 9

C. 21

D. 15

A. Proto oncogene

B. Bacterial antigen

D. Oncogene

A. Appendicitis

B. Myocardial infarction

D. Meningitis

B. Cytotoxic T lymphocytes

C. Humoral mechanism

D. Natural killer cells

A. Petechiae

C. Ecchymosis

D. Malena

A. Tendency to grow rapidly

B. Abnormal mitosis

C. Size of the lesion

A. Hydrocortisone

B. Dicoumarol

C. Lidnocaine